Biotech Investment
Anthropic’s one-person biotech buy; Jake Van Naarden’s dealmaking strategy; and more
By Max Gelman · 10/31/2026

Hello and welcome back to a spooky Halloween edition of Endpoints Weekly! Sorry to all the candy corn lovers out there, but just noting that they’re actually made with bug secretions. The Atlantic has all ...
This is a preview. Read the complete article on Endpoints News.
Read the full article →